Agilent Technologies's Revenue by Segment
In fiscal year 2025, Agilent Technologies's revenue by segment (products & services) are as follows:
- Agilent CrossLab: $2.91 B
- Applied Markets: $1.31 B
- Life Sciences and Applied Markets: $2.73 B
Learn more about Agilent Technologies’s Revenue by Geography
Check out competitors to Agilent Technologies in a side-by-side comparison.
Explore additional financial metrics for Agilent Technologies.
Agilent Technologies's Revenue Share by Segment
| Agilent CrossLab | 1568000000 |
|---|---|
| Diagnostics and Genomics | 1409000000 |
| Life Sciences and Applied Markets | 3856000000 |
| Agilent CrossLab | 1644000000 |
|---|---|
| Diagnostics and Genomics | 1651000000 |
| Life Sciences and Applied Markets | 3215000000 |
| Agilent CrossLab | 2908000000 |
|---|---|
| Applied Markets | 1314000000 |
| Life Sciences and Applied Markets | 2726000000 |
The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).
In fiscal year 2023, Agilent Technologies's revenue by segment is as follows:
- Agilent CrossLab generated $1.57 B in revenue, representing 22.95% of its total revenue.
- Diagnostics and Genomics generated $1.41 B in revenue, representing 20.62% of its total revenue.
- Life Sciences and Applied Markets generated $3.86 B in revenue, representing 56.43% of its total revenue.
The biggest segment for Agilent Technologies is the Life Sciences and Applied Markets, which represents 56.43% of its total revenue.
The smallest segment for Agilent Technologies is the Diagnostics and Genomics, which represents 20.62% of its total revenue.
The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).
In fiscal year 2024, Agilent Technologies's revenue by segment is as follows:
- Agilent CrossLab generated $1.64 B in revenue, representing 25.25% of its total revenue.
- Diagnostics and Genomics generated $1.65 B in revenue, representing 25.36% of its total revenue.
- Life Sciences and Applied Markets generated $3.22 B in revenue, representing 49.39% of its total revenue.
The biggest segment for Agilent Technologies is the Life Sciences and Applied Markets, which represents 49.39% of its total revenue.
The smallest segment for Agilent Technologies is the Agilent CrossLab, which represents 25.25% of its total revenue.
The above chart shows Agilent Technologies's revenue percentage share by segment (products and services).
In fiscal year 2025, Agilent Technologies's revenue by segment is as follows:
- Agilent CrossLab generated $2.91 B in revenue, representing 41.85% of its total revenue.
- Applied Markets generated $1.31 B in revenue, representing 18.91% of its total revenue.
- Life Sciences and Applied Markets generated $2.73 B in revenue, representing 39.23% of its total revenue.
The biggest segment for Agilent Technologies is the Agilent CrossLab, which represents 41.85% of its total revenue.
The smallest segment for Agilent Technologies is the Applied Markets, which represents 18.91% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Agilent CrossLab | 22.95% | 25.25% | 41.85% |
| Diagnostics and Genomics | 20.62% | 25.36% | - |
| Life Sciences and Applied Markets | 56.43% | 49.39% | 39.23% |
| Applied Markets | - | - | 18.91% |
| Total Revenue | 100% | 100% | 100% |
Agilent Technologies's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Agilent Technologies.
In fiscal year 2025, the Agilent CrossLab generated the most revenue ($2.91 B), and the Applied Markets generated the least revenue ($1.31 B).
Agilent Technologies's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Agilent CrossLab | $1.57 B - |
$1.64 B
4.85%
|
$2.91 B
76.89%
|
| Applied Markets | - - | - - | $1.31 B - |
| Diagnostics and Genomics | $1.41 B - |
$1.65 B
17.18%
|
- - |
| Life Sciences and Applied Markets | $3.86 B - |
$3.22 B
16.62%
|
$2.73 B
15.21%
|
| Total Revenue | $6.83 B - |
$6.51 B
4.73%
|
$6.95 B
6.73%
|
Related
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
-
Pfizer Revenue by Segment
